| 摘要 |
<p>The invention provides the use of an AT1 receptor antagonist, or of a pharmaceutical salt thereof, for producing a pharmaceutical preparation for the stimulation of apoptosis and for the treatment of pathological symptoms which are substantially reduced, halted or prevented by apoptosis, and also corresponding pharmaceutical preparations.</p> |
